Related Experiment Video
Updated: Apr 17, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
744
[Attitudes towards anti-depressive therapy: acceptance vs. stigmatization].
Romina Koller1, Helmuth Haslacher, Klemens Kienesberger
1Department of Biological Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Wien, Österreich, romina.koller@meduniwien.ac.at.
Summary
Public attitudes toward antidepressant treatment reveal significant internalized stigma, even among those with depression. Destigmatization efforts are crucial for improving mental health care access and outcomes.
Area of Science:
- Psychiatry and Mental Health
- Public Health
- Social Psychology
Context:
- Public perception of antidepressant treatment is influenced by societal beliefs and personal experiences.
- Understanding attitudes towards mental health medication is vital for effective public health interventions.
- Stigma surrounding mental illness and its treatments remains a significant barrier to care.
Purpose:
- To investigate public attitudes towards antidepressant treatment.
- To assess levels of perceived and internalized stigma related to antidepressant use.
- To explore beliefs about depression and its risk factors.
Summary:
- A study of 234 individuals examined socio-demographics, psychoeducation, beliefs about antidepressant treatment, and stigma.
- While depressed individuals viewed antidepressant medication positively, both depressed and non-depressed groups exhibited stigma.
- Common beliefs linked depression to loneliness and lack of social support, with 'sickness' and 'anxiety' being primary associations.
Impact:
- Highlights the pervasive nature of stigma in antidepressant treatment, affecting both those with and without depression.
- Underscores the critical need for targeted destigmatization campaigns to improve mental health treatment seeking.
- Findings can inform public health strategies aimed at reducing stigma and promoting acceptance of antidepressant therapies.
More Related Videos
Related Concept Videos
01:28Drug Therapy
418
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
418
01:23Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
01:25Antidepressant Drugs: Overview
2.2K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.2K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
01:54The Placebo Effect
7.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
7.2K
01:30Electroconvulsive Therapy
2.3K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.3K